Page 79 - Read Online

Page 178 Genovese et al. Cancer Drug Resist 2018;1:164-80 I http://dx.doi.org/10.20517/cdr.2018.10

markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin. Acta Neuropathol 2006;111:29-38.
87. Genovese I, Fiorillo A, Ilari A, Masciarelli S, Fazi F, Colotti G. Binding of doxorubicin to Sorcin impairs cell death and increases drug
resistance in cancer cells. Cell Death Dis 2017;8:e2950.
88. Hamada H, Okochi E, Oh-hara T, Tsuruo T. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug
resistance and its detection with monoclonal antibodies. Cancer Res 1988;48:3173-8.
89. He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T. Overexpression of sorcin results in multidrug resistance in gastric cancer cells
with up-regulation of P-gp. Oncol Rep 2011;25:237-43.
90. Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H, Hashimoto N, Okumura K, Sakaeda T. Knock-down of
sorcin induces up-regulation of MDR1 in HeLa cells. Biol Pharm Bull 2007;30:1065-73.
91. Liu X, Chen L, Feng B, Liu G. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. Anat Rec (Hoboken)
2014;297:215-21.
92. Parekh HK, Deng HB, Choudhary K, Houser SR, Simpkins H. Overexpression of sorcin, a calcium-binding protein, induces a low level
of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 2002;63:1149-58.
93. Gong Z, Sun P, Chu H, Zhu H, Sun D, Chen J. Overexpression of sorcin in multidrug-resistant human breast cancer. Oncol Lett
2014;8:2393-8.
94. Hu Y, Li S, Yang M, Yan C, Fan D, Zhou Y, Zhang Y, Yagüe E, Xiong D. Sorcin silencing inhibits epithelial-to-mesenchymal transition
and suppresses breast cancer metastasis in vivo. Breast Cancer Res Treat 2014;143:287-99.
95. Tuo H, Shu F, She S, Yang M, Zou XQ, Huang J, Hu HD, Hu P, Ren H, Peng SF, Yang YX. Sorcin induces gastric cancer cell migration
and invasion contributing to STAT3 activation. Oncotarget 2017;8:104258-71.
96. Li X, Liu Y, Wang Y, Liu J, Li X, Cao H, Gao X, Zheng SJ. Negative regulation of hepatic inflammation by the soluble resistance-
related calcium-binding protein via signal transducer and activator of transcription 3. Front Immunol 2017;8:709.
97. Lei X, Liang Y, Chen J, Xiao S, Lei J, Li J, Duanmu J, Jiang Q, Liu D, Tang C, Li T. Sorcin predicts poor prognosis and promotes
metastasis by facilitating epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep 2017;7:10049.
98. Gupta K, Sirohi VK, Kumari S, Shukla V, Manohar M, Popli P, Dwivedi A. Sorcin is involved during embryo implantation via
activating VEGF/PI3K/Akt pathway in mice. J Mol Endocrinol 2018;60:119-132.
99. Li GY, Zhang L, Liu JZ, Chen SG, Xiao TW, Liu GZ, Wang JX, Wang LX, Hou M. Marine drug Haishengsu increases chemosensitivity
to conventional chemotherapy and improves quality of life in patients with acute leukemia. Biomed Pharmacother 2016;81:160-5.
100. Sun Y, Wang C, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Peng J, Liu K. Targeting P-glycoprotein and SORCIN: Dihydromyricetin
strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca(2+) -mediated apoptosis pathways in MCF-7/ADR and
K562/ADR. J Cell Physiol 2018;233:3066-79.
101. Li GY, Liu JZ, Zhang B, Yang M, Chen SG, Hou M, Wang LX. Tegillarca granosa extract Haishengsu (HSS) suppresses expression of
mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice. Adv Med Sci 2013;58:112-7.
102. Callen DF, Baker E, Simmers RN, Seshadri R, Roninson IB. Localization of the human multiple drug resistance gene, MDR1, to
7q21.1. Hum Genet 1987;77:142-4.
103. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and
tissues. Proc Natl Acad Sci U S A 1987;84:265-9.
104. Schoenlein PV. Molecular cytogenetics of multiple drug resistance. Cytotechnology 1993;12:63-89.
105. Scotto KW, Biedler JL, Melera PW. Amplification and expression of genes associated with multidrug resistance in mammalian cells.
Science 1986;232:751-5.
106. Van der Bliek AM, Van der Velde-Koerts T, Ling V, Borst P. Overexpression and amplification of five genes in a multidrug-resistant
Chinese hamster ovary cell line. Mol Cell Biol 1986;6:1671-8.
107. Abolhoda A, Wilson AE, Ross H, Danenberg PV, Burt M, Scotto KW. Rapid activation of MDR1 gene expression in human metastatic
sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 1999;5:3352-6.
108. Atalay C, Deliloglu Gurhan I, Irkkan C, Gunduz U. Multidrug resistance in locally advanced breast cancer. Tumour Biol 2006;27:309-18.
109. Brügger D, Brischwein K, Liu C, Bader P, Niethammer D, Gekeler V, Beck JF. Induction of drug resistance and protein kinase C genes
in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. Anticancer Res 2002;22:4229-32.
110. Chin KV, Tanaka S, Darlington G, Pastan I, Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance
(MDR1) gene in human renal carcinoma cells. J Biol Chem 1990;265:221-6.
111. Gekeler V, Frese G, Diddens H, Probst H. Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell
line. Biochem Biophys Res Commun 1988;155:754-60.
112. Hu XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A, Zalcberg JR. Rapid up-regulation of mdr1 expression by
anthracyclines in a classical multidrug-resistant cell line. Br J Cancer 1995;71:931-6.
113. Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely
related to increased expression of functional P-glycoprotein and MDR1 mRNA. Cancer Chemother Pharmacol 2002;49:391-7.
114. Park J, Shinohara N, Liebert M, Noto L, Flint A, Grossman HB. P-glycoprotein expression in bladder cancer. J Urol 1994;151:43-6.
115. Schneider J, Efferth T, Centeno MM, Mattern J, Rodríguez-Escudero FJ, Volm M. High rate of expression of multidrug resistance-
associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue. Eur J Cancer 1993;29A:554-8.
116. Flahaut M, Mühlethaler-Mottet A, Martinet D, Fattet S, Bourloud KB, Auderset K, Meier R, Schmutz NB, Delattre O, Joseph JM, Gross
N. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance